A carregar...
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial
Background: Excessive daytime somnolence (EDS) commonly complicates Parkinson's disease (PD). The aetiology of EDS is probably multifactorial but is probably exacerbated by dopaminergic medications. Modafinil is a wake-promoting agent approved for use in narcolepsy, but it is often used to trea...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1739456/ https://ncbi.nlm.nih.gov/pubmed/16291885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2005.065870 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|